Related Experiment Video
Updated: Mar 23, 2026

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
Published on: January 31, 2020
Schnitzler Syndrome: A Dramatic Response to Anakinra
Ana Isabel Gouveia1, Manuela Micaelo2, Francesca Pierdomenico3
1Hospital de Santa Maria, University Clinic of Dermatology, Lisbon, Portugal. anaisabelgouveia@hotmail.com.
Abstract:
Schnitzler syndrome is a rare acquired systemic disease with a chronic evolution and difficult treatment. We report a 50-year-old woman with Schnitzler syndrome for 10 years, with major impact on her quality of life and refractory to conventional therapies. The patient was started on anakinra, an IL-1 receptor antagonist, with a rapid and sustained remission of the syndrome manifestations.
More Related Videos
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Nephrotic Syndrome I : Introduction
Allergic Reactions
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Allergic Reactions: Anaphylaxis
Rheumatic Heart Disease I: Introduction
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...